4.4 Article

Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center

Journal

BMC HEALTH SERVICES RESEARCH
Volume 18, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12913-018-3727-0

Keywords

Acute myocardial infarction; Validation study; Positive predictive value; database; Case mix; Diagnosis procedure combination

Ask authors/readers for more resources

BackgroundIn Japan, several large healthcare databases have become available for research since the early 2000's. However, validation studies to examine the accuracy of these databases remain scarce. We conducted a validation study in order to estimate the positive predictive value (PPV) of local or ICD-10 codes for acute myocardial infarction (AMI) in Japanese claims. In particular, we examined whether the PPV differs between claims in the Diagnosis Procedure Combination case mix scheme (DPC claims) and in non-DPC claims.MethodsWe selected a random sample of 200 patients from all patients hospitalized at a large tertiary-care university hospital between January 1, 2009 and December 31, 2011 who had an inpatient claim assigned a local or ICD-10 code for AMI. We used a standardized data abstraction form to collect the relevant information from an electronic medical records system. Abstracted information was then categorized by a single cardiologist as being either definite or not having AMI.ResultsIn a random sample of 200 patients, the average age was 67.7years and the proportion of males was 78.0%. The PPV of the local or ICD-10 code for AMI was 82.5% in this sample of 200 patients. Further, of 178 patients who had an ICD-10 code for AMI based on any of the 7 types of condition codes in the DPC claims, the PPV was 89.3%, whereas of the 161 patients who had an ICD-10 code for AMI based on any of 3 major types of condition codes in the DPC claims, the PPV was 93.8%.ConclusionThe PPV of the local or ICD-10 code for AMI was high for inpatient claims in Japan. The PPV was even higher for the ICD-10 code for AMI for those patients who received AMI care through the DPC case mix scheme. The current study was conducted in a single center, suggesting that a multi-center study involving different types of hospitals is needed in the future. The accuracy of condition codes for DPC claims in Japan may also be worth examining for conditions other than AMI such as stroke.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Public, Environmental & Occupational Health

Post-marketing surveillance in Japan: Potential best way forward

Shinzo Hiroi, Kiyoshi Kubota, Izumi Mishiro, Jovelle L. Fernandez

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Article Medicine, General & Internal

Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening

Nobuhiro Ooba, Soko Setoguchi, Tsugumichi Sato, Kiyoshi Kubota

BMJ OPEN (2017)

Article Medical Laboratory Technology

Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database

Nobuhiro Ooba, Daisuke Tsutsumi, Naoko Kobayashi, Shinji Hidaka, Hiroyuki Hayashi, Taku Obara, Michihiro Satoh, Kiyoshi Kubota, Noriyasu Fukuoka

THERAPEUTIC DRUG MONITORING (2018)

Article Multidisciplinary Sciences

The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan

Kiyoshi Kubota, Nobuhiro Ooba, Yukari Kamijima, Kuniyasu Sato, Daisuke Koide

PLOS ONE (2018)

Article Public, Environmental & Occupational Health

Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges

Edward Chia-Cheng Lai, Patrick Ryan, Yinghong Zhang, Martijn Schuemie, N. Chantelle Hardy, Yukari Kamijima, Shinya Kimura, Kiyoshi Kubota, Kenneth K. C. Man, Soo Yeon Cho, Rae Woong Park, Paul Stang, Chien-Chou Su, Ian C. K. Wong, Yea-Huei Yang Kao, Soko Setoguchi

CLINICAL EPIDEMIOLOGY (2018)

Article Multidisciplinary Sciences

Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study

Kiyoshi Kubota, Yukari Kamijima, Yea-Huei Kao Yang, Shinya Kimura, Edward Chia-Cheng Lai, Kenneth K. C. Man, Patrick Ryan, Martijn Schuemie, Paul Stang, Chien-Chou Su, Ian C. K. Wong, Yinghong Zhang, Soko Setoguchi

PLOS ONE (2018)

Article Multidisciplinary Sciences

Comparison between high and low potency statins in the incidence of open-angle glaucoma: A retrospective cohort study in Japanese working-age population

Nobuhiro Ooba, Rira Iwahashi, Akiko Nogami, Toshimitsu Nakayama, Atsushi Kanno, Naohiro Tochikura, Susumu Ootsuka, Noriyasu Fukuoka

PLOS ONE (2020)

Article Pharmacology & Pharmacy

Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study

Nobuhiro Ooba, Yoshinori Takahashi, Marina Nagamura, Masao Takahashi, Makoto Ushida, Eiji Kawakami, Masaomi Kimura, Tsugumichi Sato, Junichi Tokuyoshi, Choichiro Miyazaki, Mitsuaki Shimada

Summary: Based on a retrospective cohort study using records of community pharmacies in Japan, the study found no new safety concerns related to elobixibat and lubiprostone use for treating chronic constipation, although the hazard ratio of different events varied. Further larger-scale study is needed for more stable estimates.

EXPERT OPINION ON DRUG SAFETY (2021)

Article Public, Environmental & Occupational Health

Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population

Kiyoshi Kubota, Nobuhiro Ooba

Summary: This study compared the effectiveness and safety of reduced or standard daily doses of direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial fibrillation (NVAF). The results showed that the patients receiving reduced or standard doses of DOACs had equal to or lower risk of stroke or systemic embolism compared to those taking warfarin. In specific patient groups, such as those with a history of cerebral infarction and CHA(2)DS(2) -VASc score >= 3, the risk was lower for reduced doses of DOACs.

CLINICAL EPIDEMIOLOGY (2022)

Article Pharmacology & Pharmacy

Event Monitoring and Evaluation by Community Pharmacists in Japan: A

Masao Takahashi, Nobuhiro Ooba, Marina Nagamura, Makoto Ushida, Eiji Kawakami, Masaomi Kimura, Tsugumichi Sato, Yoshinori Takahashi, Junichi Tokuyoshi, Hajime Hashiba, Miwako Kamei, Choichiro Miyazaki, Mitsuaki Shimada

Summary: This study investigates the association between detected events and the use of pemafibrate using pharmacy records maintained by community pharmacists. The results show that events related to pemafibrate use mainly include increased blood pressure and lipid-lowering effects, while events related to fenofibrate use include nasopharyngitis, pruritus, dizziness, and lipid-lowering effects. Additionally, pemafibrate users are more likely to use an add-on anti-hypertensive drug compared to fenofibrate users.

CURRENT DRUG SAFETY (2022)

Article Pharmacology & Pharmacy

Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study

Rie Nakajima, Nobuhiro Ooba, Miwako Kamei, Hajime Hashiba, Choichiro Miyazaki

Summary: This study compared the safety risks of gabapentinoids, pregabalin and mirogabalin, in post-marketing clinical settings. Although no new serious safety concerns were found, mirogabalin users had an increased risk of certain common adverse events. Further studies are needed to obtain more accurate results.

EXPERT OPINION ON DRUG SAFETY (2023)

Article Pharmacology & Pharmacy

Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus

Nobuhiro Ooba, Shoutarou Tanaka, Yu Yasukawa, Nariyasu Yoshino, Hiroyuki Hayashi, Shinji Hidaka, Toshiichi Seki, Noriyasu Fukuoka

JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2016)

No Data Available